Page 21 - CPG endometrial cancer
P. 21
การให้คำแนะนำและประเมินความเส่ยี งทางพันธุกรรมสำหรบั มะเรง็ เต้านมและมะเรง็ รงั ไข่
เอกสารอ้างองิ 6. Kurian AW, Ward KC, Hamilton AS, Deapen
1. Robson ME, Bradbury AR, Arun B, Domchek DM, Abrahamse P, Bondarenko I, et al. Uptake,
SM, Ford JM, Hampel HL, et al. American Society Results, and Outcomes of Germline Multiple-
of Clinical Oncology Policy Statement Update: Gene Sequencing After Diagnosis of Breast
Genetic and Genomic Testing for Cancer Cancer. JAMA Oncol. 2018;4(8):1066-72.
Susceptibility. J Clin Oncol. 2015;33(31):3660-7.
2. Berliner JL, Fay AM, Cummings SA, Burnett
B, Tillmanns T. NSGC practice guideline: risk
assessment and genetic counseling for
hereditary breast and ovarian cancer. J Genet
Couns. 2013;22(2):155-63.
3. Weitzel JN, Blazer KR, MacDonald DJ, Culver
JO, Offit K. Genetics, genomics, and cancer risk
assessment: State of the Art and Future
Directions in the Era of Personalized Medicine.
CA Cancer J Clin. 2011;61(5):327-59.
4. Tandy-Connor S, Guiltinan J, Krempely K,
LaDuca H, Reineke P, Gutierrez S, et al. False-
positive results released by direct-to-consumer
genetic tests highlight the importance of clinical
confirmation testing for appropriate patient
care. Genet Med. 2018;20(12):1515-21.
5. COMMITTEE ON BIOETHICS COG, AND,
AMERICAN COLLEGE OF MEDICAL GENETICS
AND, GENOMICS SOCIAL, ETHICAL, & LEGAL
ISSUES COMMITTEE. Ethical and policy issues in
genetic testing and screening of children.
Pediatrics. 2013;131(3):620-2.
12
